Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims

  • S. Matsubara
  • R. C. Arora
  • H. Y. Meltzer
Full Papers


The density of 5-HT1A binding using3H-8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) as binding ligand, was studied in human frontal cortex of suicide victims and normal controls who died due to medical disease or accidentally. There was no difference in the maximum number of binding site (Bmax) or Kd (an inverse measure of affinity) of 5-HT1A receptor binding sites between normal controls and the entire group of suicide victims. However, nonviolent suicides had significantly higher Bmax (22—25%) compared to both controls and violent suicides. A negative correlation between age and Bmax of 5-HT1A binding sites was found in male controls but not in female controls or suicide victims. This relationship was less apparent among the male controls over age 60.


Serotonin1A (5-HT1A) receptor brain suicide 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agren H (1980) Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolism in the cerebrospinal fluid. II. Suicide. Psychiatry Res 3: 225–236Google Scholar
  2. Allen SJ, Benton JS, Goodhardt MJ, Haan EA, Sims NR, Smith CCT, Spillane JA, Bowen DM, Davison AN (1983) Biochemical evidence of selective nerve cell changes in the normal aging human and rat brain. J Neurochem 41: 256–265Google Scholar
  3. Arato M, Tekes K, Tothfalusi L, Magyar K, Palkovits M, Demeter, Falus A (1987) Serotonergic split brain and suicide. Psychiatry Res 21: 355–356Google Scholar
  4. Arora RC, Meltzer HY (1989) Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 146: 730–736Google Scholar
  5. Asberg M, Träskman L, Thorén P (1976) 5-HIAA in the cerebrospinal fluid. Arch Gen Psychiatry 38: 1193–1197Google Scholar
  6. Asberg M, Bertilsson L, Rydin E, Shalling D, Thorén P, Träskman-Bendz L (1980) Monoamine metabolism in cerebrospinal fluid in relation to depressive illness, suicidal behavior and personality. In: Angrist B, Burrows GD, Lader M, Lingjaerde O, Sedvall G, Wheatley D (eds) Recent advances in neuropsychopharmacology. Pergamon Press, New York, pp 257–271Google Scholar
  7. Asberg M, Schalling D, Träskman-Bendz L, Wagner A (1987) Psychobiology of suicide, impulsivity, and related phenomena. In: Meltzer HY (ed) Psychopharmacology. The third generation of progress. Raven Press, New York, pp 655–668Google Scholar
  8. Banki CM, Arato M (1983) Amine metabolism and neuroendocrine responses related to depression and suicide. J Affect Dis 5: 223–232Google Scholar
  9. Banki CM (1977) Correlations between anxiety and related symptoms with cerebrospinal fluid 5-hydroxyindoleacetic acid in depressed women. J Neural Transm 41: 135–143Google Scholar
  10. Bennett JP Jr, Enna SJ, Bylund DB, Gillin JC, Wyatt RJ, Snyder SH (1979) Neurotransmitter receptors in frontal cortex of schizophrenics. Arch Gen Psychiatry 36: 927–934Google Scholar
  11. Beskow J, Gottfries CG, Ross B-E, Winblad B (1976) Determination of monoamine and monoamine metabolites in the human brain. Acta Psychiatr Scand 53: 7–20Google Scholar
  12. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF (1979) Aggression in human correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1: 131–139Google Scholar
  13. Cheetham SC, Cromptom MR, Katona CLE, Horton RW (1988) Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res 443: 272–280Google Scholar
  14. Cheetham SC, Cromptom MR, Czudek C, Horton RW, Katona CLE, Reynolds GP (1989) Serotonin concentrations and turnover in brains of depressed suicides. Brain Res 502: 332–340Google Scholar
  15. Cochran E, Robins E, Grote S (1976) Regional serotonin levels in brain: a comparison of depressive suicides and alcoholic suicides with controls. Biol Psychiatry 11: 283–294Google Scholar
  16. Crow TJ, Cross AJ, Cooper SJ, Deakin JFW, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R, Corsellis JAN, Chambers DR, Blessed G, Perry EK, Perry RH, Tomlinson BE (1984) Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 23 (12 B): 1561–1569Google Scholar
  17. De Montigny C, Blier P, Chaput Y (1984) Electrophysiologically-identified serotonin receptors in the rat CNS. Neuropharmacology 23: 1511–1520Google Scholar
  18. Fernstrom JD, Wurtman RJ (1971) Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 173: 149–152Google Scholar
  19. Goldberg HL, Finnerty RJ (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatry 136: 1184–1187Google Scholar
  20. Goodwin GM, DeSouza RJ, Wood AJ, Green AR (1986) Lithium decreases 5-HT1A and 5-HT2 receptor and alpha2-adrenoreceptor mediated function in mice. Psychopharmacology 90: 482–487Google Scholar
  21. Hall MD, El Mestikawy S, Emerit MB, Pichat L, Hamon M, Gozlan H (1985) [3H]8- hydroxy-2(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of rat brain. J Neurochem 44: 1685–1696Google Scholar
  22. Heron DS, Shinitzky M, Hershkowitz M, Samuel D (1980) Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci 77: 7463–7467Google Scholar
  23. Hoyer D, Pazos A, Probst A, Palacios JM (1986) Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1b recognition sites. Brain Res 376: 85–96Google Scholar
  24. Kirk RE (1982) Experimental design: procedures for the behavioral sciences. Brooks/Cole Publishing Company, Ca, U.S.A.Google Scholar
  25. Kennet GA, Dourish CT, Curzon G (1987) Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur J Pharmacol 134: 265–275Google Scholar
  26. Leckman JF, Charney DS, Nelson JC, Heninger GR, Bowers MB (1980) CSF tryptophan, 5-HIAA and HVA in 132 psychiatric patients characterized by diagnosis and clinical state. Recent Adv Neuropsychopharmacol 31: 289–297Google Scholar
  27. Lloyd KG, Farley IJ, Deck JHN, Hornykiewicz O (1974) Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and controls patients. Adv Biochem Psychopharmacol 2: 387–397Google Scholar
  28. Mann JJ, Stanley M, McBride PA, McEwen BS (1986) Increased serotonin-2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43: 954–959Google Scholar
  29. Marcusson J, Oreland L, Winblad B (1984) Effect of age on human brain serotonin (S-1) binding sites. J Neurochem 43: 1699–1705Google Scholar
  30. McKeith IG, Marshall EF, Ferrier IN, Armstrong NM, Kennedy WN, Perry RH, Perry EK, Eccleston D (1987) 5-HT receptor binding in post-mortem brain from patients with affective disorder. J Affect Dis 13: 67–74Google Scholar
  31. McMillen BA, Scott SM, Williams HL, Sanghera MK (1987) Effects of gepirone, an arylpiperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission. Naunyn-Schmiedebergs Arch Pharmacol 335: 454–464Google Scholar
  32. Middlemiss DN, Palmer AM, Edel N, Bowen DM (1986) Binding of the novel serotonin agonist 8-hydroxy-2-(Di-n-propylamino)tetralinin normal and Alzheimer brain. J Neurochem 46: 993–996Google Scholar
  33. Norton WT (1981) Chapter 4. Formation, structure and biochemistry of myelin. In: Siegel GS, Albers RW, Agranoff BW, Katzman R (eds) Basic neurochemistry, pp 63–92Google Scholar
  34. Owen F, Cross AJ, Crow TJ, Deakin JFW, Ferrier IN, Lofthouse R, Poulter M (1983) Brain 5-HT2 receptor and suicide. Lancet ii: 1256Google Scholar
  35. Owen F, Chambers DR, Cooper SJ, Crow TJ, Johnson JA, Lofthouse R, Poulter M (1986) Serotonergic mechanisms in brains of suicide victims. Brain Res 326: 185–188Google Scholar
  36. Palfreyman MG, Mir AK, Kubina M, Middlemiss DN, Richards M, Tricklebank MD, Fozard J (1987) Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase. Eur J Pharmacol 130: 73–89Google Scholar
  37. Pare CMB, Yeung DPH, Price K, Stacey RS (1969) 5-Hydroxytryptamine, noradrenaline and dopamine in brainstem, hypothalamus, and caudate nucleus of control and of patients committing suicide by coal-gas poisoning. Lancet ii: 133–135Google Scholar
  38. Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple [3H]-5-hydroxytryptamine binding sites by neuroleptics spiperone in rat brain. J Neurochem 36: 220–226Google Scholar
  39. Peroutka SJ (1986) Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B and 5-HT1C binding sites in rat frontal cortex. J Neurochem 47: 529–540Google Scholar
  40. Peroutka SJ (1988) 5-Hydroxytryptamine receptor subtypes. Ann Rev Neurosci 11: 45–60Google Scholar
  41. Schoemaker H, Langer SZ (1986) [3 H]8-OH-DPAT labels the serotonin transporter in the rat striatum. Eur J Pharmacol 124: 371–373Google Scholar
  42. Schweizer EE, Amsterdam J, Rickeis K, Kaplan M, Droba M (1986) Open trial of buspirone in the treatment of major depressive disorder. Psychopharmacol Bull 22: 183–191Google Scholar
  43. Shaw DM, Camps FE, Eccleston EG (1967) 5-Hydroxytryptamine in the hind-brain of depressive suicides. Br J Psychiatry 113: 1407–1411Google Scholar
  44. Shih JC, Ohsawa R (1983) Differential effect of cholesterol on two types of 5-hydroxytryptamine binding sites. Neurochem Res 8: 701–710Google Scholar
  45. Sprouse JS, Aghajanian GK (1986) (−)-Propranolol blocks the inhibition of serotonergic dorsal raphé cell firing by 5-HT1A selective agonists. Eur J Pharmacol 128: 295–298Google Scholar
  46. Stanley M, Mann JJ (1983) Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet i: 214–216Google Scholar
  47. Stanley M, McIntrye I, Gershon S (1983) Postmortem serotonin metabolism in suicide victims. Abstract Annual Meeting, American College of NeuropsychopharmacologyGoogle Scholar
  48. Todd RD, Ciaranello RD (1987) Multiple high-affinity [3 H]serotonin binding sites in human cortex. Brain Res 400: 247–258Google Scholar
  49. van Praag HM (1983) CSF 5-HIAA and suicide in nondepressed schizophrenics. Lancet ii: 977–978Google Scholar
  50. Verge D, Daval G, Patey A, Gozland H, Mestikawy SER, Hamon M (1985) Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. Eur J Pharmacol 113: 463–464Google Scholar
  51. Verge D, Daval G, Marcinkiewicz M, Patey A, Mistikawy SER, Gozlan H, Hamon M (1986) Quantititavice autoradiography of multiple 5-HT[receptor subtypes in the brain of control or 5-7-dihydroxytryptamine-treated rats. J Neurosci 6: 3474–3482Google Scholar
  52. Woolf WA, Youdim MBH, Kuhn DH (1985) Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity? Eur J Pharmacol 109: 381–387Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • S. Matsubara
    • 1
  • R. C. Arora
    • 2
  • H. Y. Meltzer
    • 2
  1. 1.Department of PsychiatryHokkaido University School of MedicineHokkaidoJapan
  2. 2.Laboratory of Biological Psychiatry, Department of PsychiatryCase Western Reserve University, School of MedicineClevelandUSA

Personalised recommendations